001 | 177069 | ||
005 | 20240229133730.0 | ||
024 | 7 | _ | |a 10.1093/ije/dyab211 |2 doi |
024 | 7 | _ | |a pmid:34652432 |2 pmid |
024 | 7 | _ | |a 0300-5771 |2 ISSN |
024 | 7 | _ | |a 1464-3685 |2 ISSN |
024 | 7 | _ | |a altmetric:115276768 |2 altmetric |
037 | _ | _ | |a DKFZ-2021-02275 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Townsend, Mary K |0 0000-0003-2452-4477 |b 0 |
245 | _ | _ | |a Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3). |
260 | _ | _ | |a Oxford |c 2022 |b Oxford Univ. Press |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1655289460_9350 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2022 Jun 13;51(3):e73-e86 |
536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de |
700 | 1 | _ | |a Trabert, Britton |0 0000-0002-1539-6090 |b 1 |
700 | 1 | _ | |a Fortner, Renée T |0 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2 |b 2 |u dkfz |
700 | 1 | _ | |a Arslan, Alan A |b 3 |
700 | 1 | _ | |a Buring, Julie E |b 4 |
700 | 1 | _ | |a Carter, Brian D |b 5 |
700 | 1 | _ | |a Giles, Graham G |b 6 |
700 | 1 | _ | |a Irvin, Sarah R |b 7 |
700 | 1 | _ | |a Jones, Michael E |b 8 |
700 | 1 | _ | |a Kaaks, Rudolf |0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |b 9 |u dkfz |
700 | 1 | _ | |a Kirsh, Victoria A |b 10 |
700 | 1 | _ | |a Knutsen, Synnove F |b 11 |
700 | 1 | _ | |a Koh, Woon-Puay |b 12 |
700 | 1 | _ | |a Lacey, James V |b 13 |
700 | 1 | _ | |a Langseth, Hilde |b 14 |
700 | 1 | _ | |a Larsson, Susanna C |0 0000-0003-0118-0341 |b 15 |
700 | 1 | _ | |a Lee, I-Min |b 16 |
700 | 1 | _ | |a Martínez, María Elena |b 17 |
700 | 1 | _ | |a Merritt, Melissa A |b 18 |
700 | 1 | _ | |a Milne, Roger L |b 19 |
700 | 1 | _ | |a O'Brien, Katie M |b 20 |
700 | 1 | _ | |a Orlich, Michael J |0 0000-0001-7761-0622 |b 21 |
700 | 1 | _ | |a Palmer, Julie R |b 22 |
700 | 1 | _ | |a Patel, Alpa V |b 23 |
700 | 1 | _ | |a Peters, Ulrike |b 24 |
700 | 1 | _ | |a Poynter, Jenny N |b 25 |
700 | 1 | _ | |a Robien, Kim |0 0000-0002-2120-2280 |b 26 |
700 | 1 | _ | |a Rohan, Thomas E |b 27 |
700 | 1 | _ | |a Rosenberg, Lynn |0 0000-0003-2760-2987 |b 28 |
700 | 1 | _ | |a Sandin, Sven |b 29 |
700 | 1 | _ | |a Sandler, Dale P |0 0000-0002-6776-0018 |b 30 |
700 | 1 | _ | |a Schouten, Leo J |0 0000-0003-3361-7560 |b 31 |
700 | 1 | _ | |a Setiawan, V Wendy |0 0000-0001-9239-5692 |b 32 |
700 | 1 | _ | |a Swerdlow, Anthony J |0 0000-0001-5550-4159 |b 33 |
700 | 1 | _ | |a Ursin, Giske |0 0000-0002-0835-9507 |b 34 |
700 | 1 | _ | |a van den Brandt, Piet A |0 0000-0001-8781-8099 |b 35 |
700 | 1 | _ | |a Visvanathan, Kala |b 36 |
700 | 1 | _ | |a Weiderpass, Elisabete |0 0000-0003-2237-0128 |b 37 |
700 | 1 | _ | |a Wolk, Alicja |b 38 |
700 | 1 | _ | |a Yuan, Jian-Min |0 0000-0002-7664-7084 |b 39 |
700 | 1 | _ | |a Zeleniuch-Jacquotte, Anne |b 40 |
700 | 1 | _ | |a Tworoger, Shelley S |0 0000-0002-6986-7046 |b 41 |
700 | 1 | _ | |a Wentzensen, Nicolas |0 0000-0003-1251-0836 |b 42 |
773 | _ | _ | |a 10.1093/ije/dyab211 |0 PERI:(DE-600)1494592-7 |n 3 |p e73-e86 |t International journal of epidemiology |v 51 |y 2022 |x 1464-3685 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:177069 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
914 | 1 | _ | |y 2021 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-04 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-04 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2022-11-08 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-08 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b INT J EPIDEMIOL : 2021 |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-08 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-08 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-08 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b INT J EPIDEMIOL : 2021 |d 2022-11-08 |
920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C020-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|